Literature DB >> 30745566

Macrophage-dependent neutrophil recruitment is impaired under conditions of increased intestinal permeability in JAM-A-deficient mice.

Anny-Claude Luissint1, Holly C Williams2, Wooki Kim3, Sven Flemming1, Veronica Azcutia1, Roland S Hilgarth1, Monique N O' Leary1, Timothy L Denning4, Asma Nusrat1, Charles A Parkos5.   

Abstract

Junctional adhesion molecule-A (JAM-A) is a transmembrane glycoprotein expressed on leukocytes, endothelia, and epithelia that regulates biological processes including barrier function and immune responses. While JAM-A has been reported to facilitate tissue infiltration of leukocytes under inflammatory conditions, the contributions of leukocyte-expressed JAM-A in vivo remain unresolved. We investigated the role of leukocyte-expressed JAM-A in acute peritonitis induced by zymosan, lipopolysaccharide (LPS), or TNFα using mice with selective loss of JAM-A in myelomonocytic cells (LysM-Cre;Jam-afl/fl). Surprisingly, in LysM-Cre;Jam-afl/fl mice, loss of JAM-A did not affect neutrophil (PMN) recruitment into the peritoneum in response to zymosan, LPS, or TNFα although it was significantly reduced in Jam-aKO mice. In parallel, Jam-aKO peritoneal macrophages exhibited diminished CXCL1 chemokine production and decreased activation of NF-kB, whereas those from LysM-Cre;Jam-afl/fl mice were unaffected. Using Villin-Cre;Jam-afl/fl mice, targeted loss of JAM-A on intestinal epithelial cells resulted in increased intestinal permeability along with reduced peritoneal PMN migration as well as lower levels of CXCL1 and active NF-kB similar to that observed in Jam-aKO animals. Interestingly, in germ-free Villin-Cre;Jam-afl/fl mice, PMN recruitment was unaffected suggesting dependence on gut microbiota. Such observations highlight the functional link between a leaky gut and regulation of innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30745566      PMCID: PMC6543824          DOI: 10.1038/s41385-019-0143-7

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  4 in total

1.  Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis.

Authors:  A E Koch; S L Kunkel; M R Shah; S Hosaka; M M Halloran; G K Haines; M D Burdick; R M Pope; R M Strieter
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

2.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

3.  Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis.

Authors:  Derek S Wheeler; Patrick M Lahni; Alvin G Denenberg; Sue E Poynter; Hector R Wong; James A Cook; Basilia Zingarelli
Journal:  Shock       Date:  2008-09       Impact factor: 3.454

4.  Human junction adhesion molecule regulates tight junction resealing in epithelia.

Authors:  Y Liu; A Nusrat; F J Schnell; T A Reaves; S Walsh; M Pochet; C A Parkos
Journal:  J Cell Sci       Date:  2000-07       Impact factor: 5.285

  4 in total
  13 in total

Review 1.  Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.

Authors:  Clara Abraham; Maria T Abreu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2022-02-09       Impact factor: 33.883

Review 2.  Regulatory mechanisms of neutrophil migration from the circulation to the airspace.

Authors:  Wan-Chi Lin; Michael B Fessler
Journal:  Cell Mol Life Sci       Date:  2021-02-05       Impact factor: 9.261

Review 3.  The Role of Autophagy in Inflammatory Bowel Disease.

Authors:  Bo-Zong Shao; Yi Yao; Jun-Shan Zhai; Jian-Hua Zhu; Jin-Ping Li; Kai Wu
Journal:  Front Physiol       Date:  2021-02-03       Impact factor: 4.566

Review 4.  The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.

Authors:  Kamila Czubak-Prowizor; Anna Babinska; Maria Swiatkowska
Journal:  Mol Cell Biochem       Date:  2021-09-17       Impact factor: 3.396

5.  Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in Neutrophils.

Authors:  Jie Ren; Dong Yan; Yichun Wang; Jiaojiao Zhang; Min Li; Wancheng Xiong; Xueqian Jing; Puze Li; Weidong Zhao; Xiwen Xiong; Minna Wu; Genshen Zhong
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

6.  Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells.

Authors:  Shaswati Chaki; Ibrahim Alkanfari; Saptarshi Roy; Aetas Amponnawarat; Yvonne Hui; Carole A Oskeritzian; Hydar Ali
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

7.  Astrocytic junctional adhesion molecule-A regulates T-cell entry past the glia limitans to promote central nervous system autoimmune attack.

Authors:  Mario Amatruda; Candice Chapouly; Viola Woo; Farinaz Safavi; Joy Zhang; David Dai; Anthony Therattil; Chang Moon; Jorge Villavicencio; Alexandra Gordon; Charles Parkos; Sam Horng
Journal:  Brain Commun       Date:  2022-02-18

Review 8.  The Roles of Junctional Adhesion Molecules (JAMs) in Cell Migration.

Authors:  Junqi Wang; Han Liu
Journal:  Front Cell Dev Biol       Date:  2022-03-09

Review 9.  Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.

Authors:  Adam Lauko; Zhaomei Mu; Ulhas P Naik; Justin D Lathia; David H Gutmann
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

Review 10.  Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and Cancer.

Authors:  Caio S Bonilha; Robert A Benson; James M Brewer; Paul Garside
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.